Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.


n. pl. o·ro·pha·ryn·ges (-fə-rĭn′jēz) or o·ro·phar·ynx·es
The part of the pharynx between the soft palate and the epiglottis.

[Latin ōs, ōr-, mouth; see os1 + pharynx.]

o′ro·pha·ryn′ge·al (-fə-rĭn′jē-əl, -făr′ən-jē′əl) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n, pl -pharynges (-fəˈrɪndʒiːz) or -pharynxes
(Anatomy) the part of the pharynx that is at the back of the mouth
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014


(ˌɔr oʊˈfær ɪŋks, ˌoʊr-)

n., pl. -pha•ryn•ges (-fəˈrɪn dʒiz)
the part of the pharynx between the soft palate and the upper edge of the epiglottis.
o`ro•pha•ryn′ge•al (-fəˈrɪn dʒi əl, -dʒəl, -ˌfær ɪn dʒiˈ əl) adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.oropharynx - cavity formed by the pharynx at the back of the mouth
bodily cavity, cavum, cavity - (anatomy) a natural hollow or sinus within the body
pharynx, throat - the passage to the stomach and lungs; in the front part of the neck below the chin and above the collarbone
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n. orofaringe, parte central de la faringe.
English-Spanish Medical Dictionary © Farlex 2012


n (pl -rynges o -rynxes) orofaringe f
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
To prevent the molar band from entering the oropharynx, the patients' head was turned downward and he was asked to cough.
'A number of pieces of evidence suggest transmission from the oropharynx [back of the throat] may be more common than previously thought,' Professor Eric Chow and his colleagues wrote in the paper.
Based on the positive and previously published Phase 2 results, the pivotal Phase 3 clinical trial seeks to enroll approximately 190 subjects with squamous cell carcinoma of the oral cavity and oropharynx. The primary endpoint for the study is the median duration of severe oral mucositis, assessed by oral examination at each treatment visit and then through six weeks following completion of CRT.
In addition, the presence of the oncogenic viruses, human papillomavirus (HPV) and Epstein-Barr virus (EBV), in tumors arising in the oropharynx and nasopharynx increases complexity because of their major prognostic significance.
The inclusion criteria were biopsy confirmed squamous cell carcinoma of the oral cavity or oropharynx, TNM stage III and IV, treatment naive patient, KPS > 70%, no underlying medical illness and no distant metastasis at the time of diagnosis.
Angina Bullosa Haemorrhagica (ABH) is a term first introduced by Badham in 1967 to describe a benign condition of acute onset identified by presence of mostly solitary and occasionally multiple blood filled blisters in the oral cavity or oropharynx.1 It is also known as "Recurrent oral haemophlyctenosis" or "Haemorrhagic bullous stomatitis".2 ABH has an idiopathic etiology.
However, it's still not very clear, as many factors including anatomical variations of oropharynx or type of material used by manufacturer may be responsible.
We report a case of multicentric rhinosporidiosis involving the nasal cavity, oropharynx, larynx, and cheek skin without disseminated disease outside the head and neck.
Among her topics are the interview, lymph nodes, the oropharynx, male and female genitalia, the musculoskeletal system, and some bedside laboratory tricks.
Although the number of the patients is not enough to make subgroup analysis, adding cetuximab to the patients who are applied concomitant boost and who have oropharynx disease, is observed to provide more advantages of survival.
Findings are based on 267 patients with metastatic or recurrent cancer of the oral cavity, oropharynx, hypopharynx, or larynx who had not responded to prior platinum-based chemotherapy, and who had low or negative expression of the PD-L1 protein.
Considering as null hypothesis that mapping of the crude rate does not clearly identify the formation of agglomerates of deaths, and that the Empirical Bayesian analysis provides a re-configuration of the distribution of mortality and formation of agglomerates, the aim of this study was to compare the results obtained between the estimate by the crude rate and the Bayesian method for the rate of deaths from oral and oropharynx cancer, in the State of Minas Gerais, in 2012.